Echo IQ is trading 6.72% down at A$0.62, with no clear company-specific catalyst identified for September 25.

  • Shares closed at A$0.67 on September 24, 2026.
  • ASX listings show the latest material disclosure remained the September 17 EchoSolv HF FDA update. It described potential regulatory pathways but does not directly explain today’s decline.
  • Broader market indices were flat, leaving macro sentiment inconclusive.